Bromodomain Containing 7 (BRD7) Peptide
BRD7
Reactivity: Mammalian
Host: Synthetic
BP, IHC, WB
-
- Target See all BRD7 products
- BRD7 (Bromodomain Containing 7 (BRD7))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB)
- Sequence
- KELAQQVTPG DIVSTYGVRK AMGISIPSPV MENNFVDLTE DTEEPKKTDV
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of BRD7 antibody,
Alternative Names: BRD7 control peptide, BRD7 antibody Blocking Peptide, Anti-BRD7 Blocking Peptide, bromodomain containing 7 Blocking Peptide, BP75 Blocking Peptide, CELTIX1 Blocking Peptide, NAG4 Blocking Peptide, BRD7, BRD-7, BRD 7, BRD-7 Blocking Peptide, BRD 7 Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- BRD7 (Bromodomain Containing 7 (BRD7))
- Background
- BRD7 is an activator of the Wnt signaling pathway in a DVL1-dependent manner by negatively regulating the GSK3B phosphotransferase activity. It induces dephosphorylation of GSK3B at 'Tyr-216'.
- Molecular Weight
- 74 kDa
-
You are here:
